ReviewCurrent treatment options in oncology2023

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.

Alessandra Iurlo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.